| answer text |
<p>Vaccines are a precious resource and are in very high demand across the world;
therefore, for security reasons it is not possible to provide detail about the size
of our supplies or give exact detail about future deliveries.</p><p> </p><p>We have
been monitoring the requirements across the supply chain from supplier through to
patients for some time. All vaccine candidates’ supply and onward deployment have
clear supply chain plans across the value chain, including materials, manufacturing,
transportation, storage, and distribution.</p><p> </p><p>As of 18 January 2021, over
4.6 million people in the UK had been vaccinated with the first dose of the vaccine.
We are in the process of understanding the implications of Pfizer’s announcement on
15 January regarding upgrades to its manufacturing capacity. We continue to work to
meet our target of vaccinating all four priority groups, as advised by the Joint Committee
on Vaccination and Immunisation, by the middle of February.</p>
|
 |
